Biogen Inc. (BIIB)
NASDAQ · Healthcare
Biogen Inc. annual/quarterly revenue history and growth rate from 2007 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Biogen Inc. revenue for the quarter ending March 31, 2026 was 2.5 B, a 1.93% increase year-over-year.
- Biogen Inc. revenue for the twelve months ending March 31, 2026 was 10.1 B, a 3.46% increase year-over-year.
- Biogen Inc. annual revenue for 2025 was 9.9 B, a 2.22% increase from 2024.
- Biogen Inc. annual revenue for 2024 was 9.7 B, a 1.62% decrease from 2023.
- Biogen Inc. annual revenue for 2023 was 9.8 B, a 3.32% decrease from 2022.
- Biogen Inc. annual revenue for 2022 was 10.2 B.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Biogen Inc. Earnings — FAQ
Biogen Inc. (BIIB) earnings over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BIIB's earnings history?
The chart and table above show Biogen Inc.'s earnings by year and by quarter, including the growth rate.